| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 0 | 41.009 | 29.478 | 41.997 | 51.832 | 28.406 |
| Total Income - EUR | - | - | - | - | 489 | 46.765 | 35.106 | 51.443 | 60.976 | 28.406 |
| Total Expenses - EUR | - | - | - | - | 830 | 21.573 | 38.179 | 43.273 | 27.604 | 21.834 |
| Gross Profit/Loss - EUR | - | - | - | - | -342 | 25.191 | -3.073 | 8.170 | 33.372 | 6.572 |
| Net Profit/Loss - EUR | - | - | - | - | -342 | 24.811 | -3.368 | 7.750 | 32.864 | 5.300 |
| Employees | - | - | - | - | 1 | 2 | 2 | 2 | 1 | 1 |
Check the financial reports for the company - Andomed Life S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 35.877 | 34.987 | 29.018 | 34.607 | 41.860 | 30.821 |
| Current Assets | - | - | - | - | 13.329 | 18.649 | 16.156 | 14.238 | 9.035 | 27.237 |
| Inventories | - | - | - | - | 0 | 0 | 101 | 101 | 8 | 8 |
| Receivables | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 22.315 |
| Cash | - | - | - | - | 13.329 | 18.649 | 16.055 | 14.137 | 9.027 | 4.914 |
| Shareholders Funds | - | - | - | - | -299 | 24.517 | 20.605 | 28.419 | 47.050 | 52.087 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 26.529 | 4.661 | 6.281 | 11.255 | 3.845 | 5.970 |
| Income in Advance | - | - | - | - | 22.976 | 24.458 | 18.288 | 9.171 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Andomed Life S.r.l.